Active ingredients: abiraterone
What it is used for
ZYTIGA is indicated with prednisone or prednisolone for the treatment of patients with metastatic advanced prostate cancer (castration resistant prostate cancer, mCRPC): who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy (ADT) or who have received prior chemotherapy containing a taxane.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 25 degrees Celsius
- Store in Original Container
- Lifetime is 24 Months.
Always read the label. If symptoms persist see your healthcare professional.
White to off-white, oval shaped tablets with "AA250" on one side
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient abiraterone
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)